Position in NTLA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,283,411
+$7,557,742 QoQ
Shares Held
725,970
+96.9% QoQ
Ownership
0.518%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#36
of 330 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,485,861,142 across 149 Biotechnology names. NTLA ranks #43 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in NTLA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,283,411 | 725,970 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,725,669 | 368,617 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,190,972 | 354,947 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $56,352 | 3,263 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $21,911 | 2,336 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $17,191 | 2,418 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $44,832 | 3,845 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $56,322,719 | 2,740,765 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $51,493,894 | 2,300,889 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $53,086,047 | 1,929,700 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $61,476,987 | 2,016,300 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $56,017,296 | 1,771,578 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $82,378,821 | 2,020,079 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $75,288,344 | 2,020,079 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $73,500,843 | 2,106,645 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $84,757,016 | 1,514,600 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $73,411,208 | 1,418,300 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $45,026,332 | 619,600 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $65,078,113 | 550,390 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $94,821,244 | 706,830 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $121,921,792 | 753,022 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $53,047,350 | 660,985 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $27,165,129 | 499,359 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,360,133 | 118,719 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,605,738 | 76,391 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||